SCHEMBL15086792

SCHEMBL15086792

COc1ccc(C2=NN(C(=O)c3cccc(F)c3)CC2c2ccc(C#N)cc2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 1/20 0.43
▸ SCD5 Q86SK9 1/20 0.43
▸ KMT2A Q03164 1/20 0.41
▸ NR3C2 P08235 2/20 0.40
▸ CNR1 P21554 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ FASN P49327 3/20 0.38
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15086756 0.91 KMT2A (0.44) SCDSCD5KMT2AALDH1A1GRIN2C
SCHEMBL15086799 0.89 SCD (0.45) SCDSCD5KMT2ACNR1ALDH1A1
SCHEMBL15086749 0.89 SCD (0.49) SCDSCD5KMT2ACNR1ALDH1A1
SCHEMBL15086793 0.89 SCD (0.45) SCDSCD5KMT2AALDH1A1NR1H2
SCHEMBL15086744 0.89 SCD (0.45) SCDSCD5KMT2AALDH1A1GRIN2C
SCHEMBL15086788 0.88 SCD (0.40) SCDSCD5KMT2AALDH1A1GRIN2C
SCHEMBL15086754 0.87 KMT2A (0.44) KMT2ACNR1ALDH1A1MCHR1
SCHEMBL15086750 0.87 KMT2A (0.44) KMT2ACNR1ALDH1A1MCHR1
SCHEMBL15086742 0.86 KMT2A (0.41) KMT2ACNR1ALDH1A1MCHR1
SCHEMBL15086769 0.81 KMT2A (0.44) KMT2ACNR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170368030-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-12-28 — — US disclosed
US-9775830-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-10-03 — — US disclosed
US-9775830-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-10-03 — — US disclosed
US-20170071910-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-03-16 — — US disclosed
US-20170071910-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-03-16 — — US disclosed
US-9517227-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2016-12-13 — — US disclosed
US-9517227-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2016-12-13 — — US disclosed
US-20140296238-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-10-02 — — US disclosed
US-20140296238-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-10-02 — — US disclosed
US-8791114-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-07-29 — — US disclosed
US-8791114-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-07-29 — — US disclosed
US-20130172351-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2013-07-04 — — US disclosed
US-20130172351-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2013-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170368030-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR SCD 3841/4885SCD5 3658/4885KMT2A 2373/4885
US-20130172351-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR SCD 3841/4885SCD5 3658/4885KMT2A 2373/4885
US-20140296238-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR SCD 3841/4885SCD5 3658/4885KMT2A 2373/4885
US-20170071910-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR SCD 3841/4885SCD5 3658/4885KMT2A 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback